Applications: |
ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Sensitivity: |
0.105ng/mL |
Detection Limit: |
0.312-20ng/mL |
Short Description: |
This LPAR3 Sandwich ELISA Kit, Ready-To-Use is an in-vitro enzyme-linked immunosorbent assay for the measurement of samples in human cell culture supernatant, serum and plasma (EDTA, citrate, heparin). |
Storage Instruction: |
The whole kit may be stored at-20°C for up to 12 months from receipt. An unopened kit may be stored in the fridge at 2-8°C for up to 6 months. Once opened store individual kit contents according to components table provided with the kit. |
Assay Time: |
3 hrs |
Gene Symbol: |
LPAR3 |
Gene ID: |
23566 |
Uniprot ID: |
LPAR3_HUMAN |
Immunogen Region: |
Ready-To-Use |
Sample Type: |
tissue homogenates, cell lysates or other biological fluids. |
Tissue Specificity | Most abundantly expressed in prostate, testes, pancreas, and heart, with moderate levels in lung and ovary. No detectable expression in brain, placenta, liver, skeletal muscle, kidney, spleen, thymus, small intestine, colon, or peripheral blood leukocytes. |
Post Translational Modifications | |
Function | Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. May play a role in the development of ovarian cancer. Seems to be coupled to the G(i)/G(o) and G(q) families of heteromeric G proteins. |
Protein Name | Lysophosphatidic Acid Receptor 3Lpa Receptor 3Lpa-3Lysophosphatidic Acid Receptor Edg-7 |
Database Links | Reactome: R-HSA-416476Reactome: R-HSA-418594Reactome: R-HSA-419408 |
Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
Alternative ELISA Names | Lysophosphatidic Acid Receptor 3 ELISA kitLpa Receptor 3 ELISA kitLpa-3 ELISA kitLysophosphatidic Acid Receptor Edg-7 ELISA kitLPAR3 ELISA kitEDG7 ELISA kitLPA3 ELISA kit |
output | |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance